Differences

This shows you the differences between two versions of the page.

--- pharmaceutical_companies:qu_biologics [2023/05/02 04:47]
liam [Personnel]
+++ pharmaceutical_companies:qu_biologics [2024/02/10 20:13] (current)
liam [External links]
@@ Line 15: / Line 15: @@
 ==== Personnel ====
-^  Qu Biologicals - Team((//Management Team.// Qu Biologics Inc. Retrieved May 2, 2023, from https://web.archive.org/web/20230502003205/https://www.qubiologics.com/who-we-are/management-team/)) ((//Management Team.// Qu Biologics. Retrieved February 18, 2015, from https://web.archive.org/web/20150218140801/http://www.qubiologics.com/who-we-are/management-team/))  ^^^
+^  Qu Biologicals - Team((//Management Team.// Qu Biologics Inc. Retrieved May 2, 2023, from https://web.archive.org/web/20230502003205/https://www.qubiologics.com/who-we-are/management-team/)) ((//Management Team.// Qu Biologics. Retrieved February 18, 2015, from http://archive.today/2015.02.18-140801/http://www.qubiologics.com/who-we-are/management-team/)) ((//Management Team.// Qu Biologics Inc. Retrieved October 1, 2016, from http://archive.today/2016.10.01-094757/http://www.qubiologics.com/who-we-are/management-team/)) ((//Management Team.// Qu Biologics. Retrieved April 15, 2017, from http://archive.today/2017.04.15-053456/http://www.qubiologics.com/who-we-are/management-team/)) ((//Management Team.// Qu Biologics. Retrieved April 19, 2018, from http://archive.today/2018.04.19-170653/http://www.qubiologics.com/who-we-are/management-team/))  ^^^
 ^ Name  ^ Position  ^ Notes  ^
 | [[:Hal Gunn]]  | CEO and Founder  | [[:InspireHealth]], [[:University of British Columbia]] (UBC)  |
@@ Line 21: / Line 21: @@
 | [[:Ted Steiner]]  | Chief Medical Officer - Infectious Diseases  | [[:University of British Columbia]], [[:Vancouver General Hospital]] (VGH), [[:BC Children's Hospital Research Institute]], [[:Canadian Institutes of Health Research]] (CIHR), [[:Crohn's & Colitis Canada]], [[Merck]], [[:COVID-19 Immunity Task Force]] (CITF), [[:Vancouver Coastal Health Research Institute]] (VCHRI), [[:COVID-19 Clinical Research Coordination Initiative]] (CRCI)  |
 | [[:Matt Cahill]]  | Chief Operating Officer  | [[:Deep Genomics]], [[:University of Toronto]]  |
-| [[:Shirin Kalyan]]  | Vice President, Scientific Innovation  | [[:Alexander von Humboldt Foundation]]  |
+| [[:Shirin Kalyan]]  | Vice President, Scientific Innovation  | [[:Alexander von Humboldt Foundation]], [[:University of British Columbia]]  |
 | [[:David Mullins]]  | Chief Scientific Officer (former)  | [[:Norris Cotton Cancer Center]], [[:Society for the Biological Therapy of Cancer]], [[:American Association of Immunologists]]  |
 | [[:Gillian Vandermeirsch]]  | Vice President of Operations (former)  | [[:Pasteur Institute]], [[Augurex]], [[:University of British Columbia]]  |
-| [[:Bob Cory]]  | Vice President of Business Development (former)  | [[Bioasis Technologies]], [[Migenix]], [[Illumigen Biosciences]]  |
+| [[:Bob Cory]]  | Vice President of Business Development (former)  | [[Bioasis Technologies]], [[MIGENIX]], [[Illumigen Biosciences]]  |
 | [[:Julie Jang]]  | Director of Communications (former)  | [[Sirona Biochem]], [[Zalicus]], [[:CityNews 1130]], [[:Global Television Network]], [[:CTV]]  |
 | [[:Heidi Biagi]]  | Director of Project Management (former)  | [[Novadeq Technologies]], [[QLT]]  |
+| [[:Russell McAllister]]  | Vice President of Finance (former)  | [[Lakewood-Amedex]], [[:H.C. Wainwright & Co.]], [[Thomas Weisel Partners]], [[Merriman Curhan Ford & Co.]], [[PricewaterhouseCoopers]]  |
+| [[:Jim Pankovich]]  | Vice President of Clinical Operations & Drug Development (former)  | [[:CIHR Canadian HIV Trials Network]] (CTN), [[MIGENIX]], [[Inex Pharmaceuticals]], [[CV Technologies]]  |
+| [[:Kevin Harper]]  | Acting Director of Manufacturing (former)  | [[:HH Consultancy]], [[Sanofi Pasteur]], [[Novartis]]  |
+| [[:Nicole Clendinning]]  | Director of Finance (former)  | [[:Chartered Professional Accountant of British Columbia]]  |
+| [[:Alun Rees]]  | Vice President of Manufacturing (former)  | [[STEMCELL Technologies]], [[QLT]], [[GlaxoSmithKline]], [[Bio Products Laboratories]] (BPL)  |
+| [[:Mark Bazett]] (former)  | Director of Preclinical and Translational Research  | [[:Meakins-Christie Laboratories]]  |
+^  Board of Directors((//Board of Directors.// Qu Biologics Inc. Retrieved May 2, 2023, from https://web.archive.org/web/20230502044842/https://www.qubiologics.com/who-we-are/board-of-directors/))  ^^^
+| [[:Julia Levy]]  | Board member  | [[QLT]], [[:Foundation Fighting Blindness]], [[:Wilmer Eye Institute]], [[:Life Sciences British Columbia]], [[:University of British Columbia]]  |
+| [[:Karn Manhas]]  | Board member  | [[:Terramera]], [[:Young Presidents' Organization]] (YPO), [[:Unreasonable Group]]  |
+| [[:Mile Leschuk]]  | Board member  | [[:Leschuk-Weisz Developments]], [[:Rob Freeman Foundation]], [[:PricewaterhouseCoopers]], [[:London Telecom Group]]  |
+| [[:Foster Coulson]]  | Board member  | [[:Integro Cap]]  |
+| [[:Marc Lambiotte]]  | Board member  | [[:West Coast General Hospital]]  |
+^  Scientific Advisory Board((//Scientific Advisory Board.// Qu Biologics Inc. Retrieved May 7, 2023, from https://web.archive.org/web/20230507165939/https://www.qubiologics.com/who-we-are/scientific-advisory-board/))  ^^^
+| [[:Dieter Kabelitz]]  | Scientific Advisor  | [[:University of Kiel]], [[:German Society of Immunology]], [[:International Union of Immunological Societies]], [[:Rockefeller University]], [[:University of Heidelberg]], [[:Paul Ehrlich Institute]], [[:SFB 1315]], [[:Cluster of Excellence Inflammation at Interfaces]]  |
+| [[:Bruce Vallance]]  | Scientific Advisor  | [[:Child & Family Research Institute]] (CFRI), [[:Crohn’s and Colitis Canada]], [[:CH.I.L.D. Foundation]], [[:BC Children's Hospital]], [[:University of British Columbia]] (UBC)  |
+| [[:Balfour Sartor]]  | Scientific Advisor  | [[:University of North Carolina at Chapel Hill]], [[:National Gnotobiotic Rodent Resource Center]], [[:Crohn's & Colitis Foundation]]  |
+| [[:Michael Noble]]  | Scientific Advisor  | [[:University of British Columbia]]  |
+| [[:Robert E.W. Hancock]]  | Scientific Advisor  | [[:University of British Columbia]], [[:R.E.W. Hancock Laboratory]], [[MIGENIX]], [[Inimex Pharmaceuticals]], [[ABT Innovations]], [[Sepset Biotherapeutics]], [[:Centre for Drug Research and Development]] (CDRD)  |
+^  IBD Clinical Advisors((//IBD Clinical Advisors.// Qu Biologics Inc. Retrieved May 7, 2023, from https://web.archive.org/web/20230507171856/https://www.qubiologics.com/who-we-are/clinical-advisors/))  ^^^
+| [[:Brian Feagan]]  | Clinical Advisor  | [[:Schulich School of Medicine & Dentistry]], [[:London Health Sciences Centre]], [[:Robarts Research Institute]]  |
+| [[:William Sandborn]]  | Clinical Advisor  | [[:University of California San Diego]], [[:UC San Diego Health System]], [[:Mayo Clinic]]  |
+| [[:Brian Bressler]]  | Clinical Advisor  | [[:University of British Columbia]], [[:Massachusetts General Hospital]], [[:Harvard Medical School]]  |
+| [[:John Marshall]]  | Clinical Advisor  | [[:McMaster University]], [[:Hamilton Health Sciences]], [[:Farncombe Family Digestive Health Research Institute]], [[:Canadian Association of Gastroenterology]], [[:American Gastroenterological Association]]  |
 ==== Funding ====
@@ Line 43: / Line 65: @@
   * [[https://www.linkedin.com/company/qu-biologics-inc/|LinkedIn]]
   * [[https://www.qubiologics.com/|Website]]
+  * [[https://wiki.whiteroseintelligence.com/en/Qu-Biologics|White Rose Wiki]]